Emergent BioSolutions Inc.EBSNYSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-18.2%
5Y CAGR-9.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-18.2%/yr
vs +13.8%/yr prior
5Y CAGR
-9.4%/yr
Recent deceleration
Acceleration
-31.9pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $186.10M | -37.7% |
| 2024 | $298.70M | -16.3% |
| 2023 | $356.70M | +5.1% |
| 2022 | $339.50M | -2.6% |
| 2021 | $348.70M | +14.7% |
| 2020 | $304.10M | +11.2% |
| 2019 | $273.50M | +35.1% |
| 2018 | $202.50M | +41.7% |
| 2017 | $142.90M | -0.1% |
| 2016 | $143.10M | - |